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Introduction: Oral cancer is a highly relevant problem of global public health. It is part of 
the head and neck cancer which is the sixth most frequent among all types of cancer, and one 
of the ten most common causes of death. Oral squamous cell carcinoma (OSCC) comprises 
more than 90% of oral cancers. Despite the progress in research and therapy, survival rate of 
OSCC has remained 50% for the last 50 years. However, a 70%-90% survival rate can be 
achieved if the cancer is detected at an early stage. Modifiable risk factors such as tobacco 
and alcohol use accounts for the major risk factors, and around 70% of oral cancers are 
preceded by precancerous lesions. It is therefore important to perform thorough oral mucosal 
examination for early detection of potentially malignant changes in the mucosa. This justifies 
intense efforts to equip the oral health professional with knowledge on correct examination of 
oral mucosa, recognizing potentially malignant lesions of oral mucosa and early lesions of 
OSCC, as well as on oral cancer prevention.  
 
Aim: The overall aim of this study was to investigate knowledge, attitudes and practices 
related to oral cancer prevention and oral mucosal examination among dentists in Norway.  
 
Methods: The study was a cross-sectional survey based on an electronically administered 
questionnaire. Study population comprised all actively practicing dentists currently employed 
in the Public Dental Health Care (PDHC) in Norway. The project was registered in Norway 
at the Norwegian Centre for Research Data (NSD).  
 
Results: The overall response rate in the present study was 23.7%. Tobacco and prior oral 
cancer lesions were correctly identified as the main risk factors by majority of the dentists. 
Whereas wide variability was observed in the knowledge regarding the most common sites 
for oral cancer, rim of the tongue and floor of the mouth were correctly identified by most of 
the participants (68.2% and 60.7% respectively). Erythroplakia (83.2%) and leukoplakia 
(80.4%) were identified correctly by most of the participants in the study as the most 
prevalent lesion with malignant potential. “Small, painless, indurated ulceration” was 
identified by 73.6% of the participants, while other common clinical presentations, such as 
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“small, painless white and red area” were correctly listed by 31.4% and 46.4% respectively. 
A large number of the participants reported to give counselling to their patients regarding 
tobacco cessation, while giving counselling regarding excessive alcohol use was not so 
common. Majority of the respondents reported to perform examination of oral mucosa on 
both new (83.3%) and recall (77.7%) patients. The most common listed barriers to 
performing oral mucosal screening were reported to be lack of training and/or experience. 
 
Conclusions: Results from the current study highlight strengths as well as gaps in dentists’ 
knowledge and practices related to oral cancer prevention and mucosal examination. Data 
from this study can be used as foundation to reinforce dental curriculum in order to enhance 




Table of Contents 
 
Abstract ....................................................................................................................................... 2 
 




Abbreviations .............................................................................................................................. 8 
 
1.0 Introduction ......................................................................................................................... 10 
1.1 Oral cancer .................................................................................................................................. 11 
1.1.1 Risk factors ........................................................................................................................... 15 
1.1.2 Diagnosis of oral cancer ....................................................................................................... 17 
1.2 Norway ........................................................................................................................................ 20 
1.2.1 The Norwegian healthcare system: ..................................................................................... 20 
1.2.2 General health status in Norway ......................................................................................... 22 
1.2.3 The oral healthcare in Norway ............................................................................................ 23 
1.2.4 Education and training of oral health professionals............................................................ 25 
1.2.5 Oral health status in Norway ............................................................................................... 26 
1.2.6 Oral cancer in Norway ......................................................................................................... 27 
 
2.0 Rationale of the study .......................................................................................................... 27 
 
3.0 Aims .................................................................................................................................... 30 
3.1 The overall aim ........................................................................................................................... 30 
3.2 Specific objectives ....................................................................................................................... 30 
 
4.0 Methodology ....................................................................................................................... 30 
4.1 Study area ................................................................................................................................... 31 
4.2 Study design and study population ............................................................................................ 31 
4.3 Survey instrument and questionnaire ........................................................................................ 32 
4.4 Variables and measures of the questionnaire ............................................................................ 32 
4.5 Data collection and measurements ............................................................................................ 35 
4.5.1 Recruitment and data collection from the dentists: ........................................................... 35 
4.5.2 Recruitment plan for dentists: ............................................................................................. 35 
4.6 Data management ...................................................................................................................... 36 
4.7 Statistical methods ..................................................................................................................... 36 
4.8 Ethical consideration .................................................................................................................. 36 
5 
 
5.0 Results ................................................................................................................................. 37 
5.1 Response rate and sample profile .............................................................................................. 37 
5.2 Assessment of knowledge on oral cancer prevention and early detection ............................... 39 
5.3 Assessment of practices related to oral cancer prevention and early detection ...................... 43 
5.4 Assessment of opinions towards oral mucosal screening and oral cancer prevention ............. 46 
5.5 Assessment of behaviours towards tobacco use ....................................................................... 48 
5.6 Perceived barriers to perform oral mucosal screening .............................................................. 50 
 
6.0 Discussion ............................................................................................................................ 51 
6.1 Discussion of methodology:........................................................................................................ 51 
6.2 Discussion of the results: ............................................................................................................ 53 
6.2.1 Knowledge on of oral cancer prevention and early detection: ........................................... 53 
6.2.2 Practices related to oral cancer prevention and early detection ........................................ 56 
6.2.3Opinions towards oral mucosal screening and oral cancer prevention ............................... 58 
6.2.4 Perceived barriers to perform oral mucosal screening ....................................................... 59 
 
7.0 Conclusion: .......................................................................................................................... 61 
 
8.0 Recommendations: .............................................................................................................. 62 
 
9.0 References: .......................................................................................................................... 63 
 
Appendices ................................................................................................................................ 71 
Appendix 1. Questions/statements and corresponding scores of questions on knowledge 
regarding oral cancer risk factors, cancer sites and clinical properties. ...................................... 71 
Appendix 2. Questionnaire on oral mucosal screening and oral cancer prevention ................... 73 





Definition of Terms 
 
Dentists’ knowledge: To assess dentists’ knowledge on oral cancer, questions regarding 
oral cancer risk factors, most common lesions with malignant potential, risk sites and clinical 
properties of an early cancer lesion were included in the present study.  
 
Dentists’ opinions:  To obtain dentists’ viewpoint on oral mucosal screening and oral 
cancer prevention, the survey contained following questions:  
 whether oral mucosal examination should be performed among all new and recall 
patients  
 who should be responsible for performing oral mucosal screening.  
 whether patients can be persuaded to quit/reduce smoking and consumption of alcohol  
 
Dentists’ practices: To evaluate practices related to oral cancer prevention and oral 
mucosal examination, the survey included questions on screening practices, including oral 
examination as well as assessment of own tobacco/alcohol usage; urging the patients to limit 
or cease tobacco/alcohol consumption; dentists’ way of handling when detecting a suspicious 
lesion.  
 
Perceived barriers: Questions were asked whether lack of knowledge, clinical time 
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Noncommunicable diseases (NCDs) are the leading cause of mortality in the world. NCDs 
such as heart disease, stroke, cancer, chronic respiratory diseases and diabetes account for 
70% of global deaths (1). People of all age groups, regions and countries are affected by 
NCDs (2). It results in 38 million deaths and disability every year worldwide, with three 
quarters of the total deaths occurring in low and middle-income countries (LMICs). NCDs 
prevention and control is an urgent health and development challenge for the 21st century. 
Reducing the burden of NCDs is essential to ending extreme poverty, reducing inequality, 
and improving health and well-being (3).  
 
According to World Health Organization (WHO), cancer is a large group of diseases that can 
start in almost any organ or tissue of the body when abnormal cells grow uncontrollably, go 
beyond their usual boundaries to invade adjoining parts of the body and/or spread to other 
organs (4). Cancer arises from the transformation of normal cells into tumour cells in a 
multistage process that generally progresses from a pre-cancerous lesion to a malignant 
tumour. It is the second leading cause of death globally which accounts for an estimated 9.6 
million deaths (5). According to cancer statistics in 2018, about one in six deaths was 
reported to be cancer (5, 6). Cancer burden continues to grow at an alarming rate globally, 
exerting tremendous physical, emotional and financial strain on individuals, families, 
communities and health systems (4). Mortality due to cancer is further projected to increase 
to 11 million deaths in 2030, with the majority occurring in regions of the world with the 
least capacity to respond (7). Europe comprises only one eighth of the total world population 
but has around one quarter of the global total cancer cases. Cancer represents the second most 
important cause of death and morbidity in Europe with more than 3.7 million new cases and 
1.9 million deaths each year (8). Incidence and mortality data in Europe are a key resource in 
both planning and assessing the impact of cancer control programmes at the country and 
regional level (9). 
 
There are more than 100 different types of cancer known. The types of cancer are usually 
named after the organs or tissues where they arise from (10). Oral cancer, also known as 
mouth cancer, is one of several types of cancers grouped in a category called head and neck 
cancers (11). Head and neck cancer represents one of the most common cancer in the world, 
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with oral cancer accounting for the majority the of cases, and over 90% being of the 
histological type of squamous cell carcinoma (SCC). Oral squamous cell carcinoma (OSCC) 
ranks among the most understudied cancers with limited information available about 
molecular mechanisms underlying its aetiology and progression (12). Studies suggest that 
oral diseases are the fourth most expensive disease to treat and it has been estimated that if 
treatments were available for all, the cost of dental caries in children only would exceed the 
total healthcare budget for the children (13). Direct treatment costs due to oral diseases 
worldwide were estimated at US$298 billion yearly, corresponding to an average of 4.6% of 
global health expenditure. Indirect costs due to dental diseases worldwide amounted to 
US$144 billion yearly, corresponding to economic losses within the range of the 10 most 
frequent global causes of death (13). Oral cancer is a highly relevant problem of global public 
health. It is one of the ten most common causes of death (14) and despite the progress in 
research and therapy, survival has not improved significantly in the last years (15). Hence, 
the major goal should be to focus on preventive measures and early detection at the first place 
so that mortality due to oral cancer is reduced and is under control (16).  
 
1.1 Oral cancer 
 
According to Fédération Dentaire Internationale (FDI), oral cancer is any cancerous tissue 
growth located in the oral cavity (17). The oral cavity includes the lips, the lining of the lips 
and cheeks (buccal mucosa), the teeth, the gums, the front two-thirds of the tongue, the floor 
of the mouth, and the hard palate. The part of the throat just behind the oral cavity is often 
referred to as oropharynx (18). According to epidemiological data, oral cavity cancer is the 
part of head and neck cancer and it is the sixth most frequent among all types of cancer, with 
an incidence of 10 in 100,000 people (14). Malignant oral cavity tumours account for about 
3-5% of all tumours (14). Oral cancers most commonly begin in the flat, thin cells called 
squamous cells that forms the lining of lips and the inside of the mouth (11). It is therefore 
traditionally also defined as squamous cell carcinoma of the lip and oral cavity (19). 
 
SCC (fig-1) accounts for more than 90% of malignancies originating from the oral mucosa 
(20). It is a disease found mainly in older people with 90% of the OSCC patients being over 
45 years age (21). Head and neck cancer, including oral squamous cell carcinoma (OSCC), 
has an estimated 300,400 cases and 145,400 OSCC-related deaths occurring in 2012. OSCC 
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is one of the leading causes of morbidity and mortality in Melanesia, South Central Asia, and 
Central and Eastern Europe (22). In Europe cancer of the oral cavity and oropharynx was 
responsible for 67 000 new cases in 2004 and 73 000 new cases and 28 200 deaths in 2012. 
Overall in the European Union (EU), oral and pharyngeal cancer occupies the 7th position 
(23). Since most of the early-stage oral squamous cell carcinomas usually do not cause 
visible changes in the oral cavity, lack of applicable markers for early detection and the 
failure of advanced lesions to respond to chemotherapy contribute to poor OSCC prognosis 
and outcomes (24). Despite great progress in chemotherapy, radiotherapy, and targeted 
therapy in the last three decades, the prognosis of OSCC is poor due to aggressive local 
invasion and metastasis, leading to recurrence. The 5-year survival has remained 
approximately 50% for the last 50 years due to inability of early detection of OSCC and 
precursor lesions (19). Thus, OSCC is still a challenging disease to treat (25). This also 
justifies intense efforts to equip the oral health professional with knowledge on correct 
examination of oral mucosa, recognizing premalignant lesions of oral mucosa and early 
lesions of OSCC, as well as on oral cancer prevention (25). WHO proposed in 1978 that 
clinical presentations of the oral cavity that are recognized as precancerous also referred to as 
potentially malignant disorders be classified into two broad groups, as lesions and conditions 
(Table-1) (26).  
 
  
Figure 1: (A) OSCC manifesting on the anterior floor of the mouth (27) and (B) OSCC on 






Table 1. Classification of lesions and conditions with malignant potential (26). 
 
 
Table 2. The malignant transformation rates of potentially malignant disorders (PMDs) (29). 
 
 
Studies have suggested that up to 70 % of oral cancers are preceded by precancerous oral 
lesions, such as persistent red or white patches in the mouth (30). The most common oral 
lesions with premalignant potential include oral leukoplakia, oral erythroplakia and oral 
submucous fibrosis (31). It is estimated that 85% of oral potentially malignant lesions may 
present as leukoplakias (32). According to WHO definition, leukoplakia is a white patch or 
plaque in the oral cavity that cannot be scraped and cannot be characterized clinically or 
pathologically as any other disease (33). It is the most common oral disorder with malignant 
potential, observed in 20.65% of patients (28). Malignant transformation of oral leukoplakia 
varies in the range from 0.13%−17.5% (28). Leukoplakias are often reported to be painless 
patches and plaques in the oral cavity. However, people who have an underlying condition, 
including cancer, may experience some level of pain (34). The lesion mainly occurs above 
the age of 30–40 years and it is much more common in male smokers than in non-smokers 
(35). The size may vary from a quite small and circumscribed plaque to an extensive lesion 
involving a large area of mucosa. Lesions may be white, whitish yellow, or grey. Some 
lesions appear homogeneous while others are nodular or speckled, showing nodular white 
excrescences on an erythematous base (36). Leukoplakia arising on the floor of mouth, lateral 
rim of the tongue, and lower lip are the most likely to progress to malignancy (29). 
 
  
Potentially malignant disorders (PMDs) Malignant transformation rate (%) 
Erythroplakia 14 ~ 50 
Leukoplakia 0.13 ~ 17.5 
Oral submucous fibrosis 7 ~ 30 
Lichen planus 0 ~ 10 
Precancerous lesions Precancerous conditions
Leukoplakia Oral submucous fibrosis
Erythroplakia Actinic keratosis
Erythroleukoplakia Lichen planus




Figure 2: (A) Leukoplakia of the floor of the mouth (35) and (B) Leukoplakia of the palate 
(34). 
 
According to WHO, oral erythroplakia (OE) is defined as a fiery red patch that cannot be 
scraped and cannot be characterized either clinically or pathologically as any other definable 
lesion (34). It appears as smooth, velvety, granular or nodular lesions often with a well-
defined margins adjacent to normal looking mucosa (34). The soft palate, the floor of the 
mouth and the buccal mucosa are most affected by erythroplakia. Clinically, the typical 
lesion of OE is less than 1.5 cm in diameter and half of them are less than 1 cm, but lesions 
larger than 5 cm have also been observed (37). Erythroplakia shows 17 times higher 
incidence of malignant change than leukoplakia. Approximately 75-90% of lesions were 
proven to be carcinomas or were severely dysplastic (38). Prevalence of erythroplakia varies 
between 0.02% and 0.83%. It mainly occurs in the middle aged and the elderly population 
with male gender most frequently affected (39). Although erythroplakia is less common than 
the leukoplakia, malignant transformation rate is much higher (varies from 14% to 50%), so 






Figure 3: (A) Erythroplakia on the surface of tongue (40) and (B) Erythroplakia on the 
buccal mucosa (41). 
 
Majority of the early oral cancers usually present as a white patch, a red patch, an ulcer, a 
lump, or a raised area. It is therefore important to have any new or changing lesions in the 
mouth checked by an oral healthcare professional (42). Only 30% of oral and pharyngeal 
cancers are identified at an early stage, while 50% are diagnosed at an advanced stage, with 
metastasis (stage III or IV) (43). This is largely due to late presentation, delayed diagnosis, 
and lack of clear referral pathways between dentists and medical doctors. Oral mucosal 
screening must therefore be an essential component of the routine head and neck examination 
conducted in the primary dental care setting (43). One approach to this problem would be to 
improve the ability of oral health care professionals to detect relevant potentially malignant 
lesions or cancerous lesions at their earliest or most incipient stage (19). Such a goal could be 
also achieved by increasing public awareness about the importance of regular oral screening 
or case finding examinations to identify small, otherwise asymptomatic cancers and 
precancerous lesions (19).  
 
1.1.1 Risk factors 
 
Oral carcinogenesis is a complex process resulting from accumulation of multiple genetic and 
epigenetic alterations induced by oral carcinogens and/or human papilloma virus (HPV) (44). 
It causes an alterations in tumour suppressor genes, which occurs when epithelial cells are 
affected by various genetic alterations (43). Some factors such as age, sex, and hereditary 
conditions, are intrinsic to the individual and cannot be changed, thus they are considered to 




considered to be modifiable risk factors (30). The modifiable risk factors of oral diseases 
include tobacco use, excessive alcohol consumption, and an unhealthy diet, particularly one 
with low consumption of fruits and vegetables (30, 43). Oral cancers have a multifactorial 
aetiology and risk factors which may vary across different parts of the world. Historically, 
tobacco products and alcohol consumption have been considered primary causes of oral 
cancers across the globe (45). 
 
Since over a century, tobacco use has emerged as an epidemic with its rapid spread and used 
commonly in two forms, smoked and smokeless. Cigarettes, which is smoked tobacco are the 
most widely used tobacco products worldwide (46). Other forms of smoked tobacco products 
include cigars, narghiles, and pipes. Whereas in smokeless forms, chewable tobacco (often 
combined with areca nut and used in betel quid in many Asian countries), snuff which is 
inhaled, and e-cigarettes are used more commonly (46, 47). Around 90% of oral cancer are 
attributable to the use of tobacco globally (18). Epidemiological studies show that the risk of 
developing oral cancer is five to nine times greater for smokers than for non-smokers, and 
this risk may increase to as much as 17 times greater for extremely heavy smokers of 80 or 
more cigarettes per day (48). A six-fold increase in the risk of developing leukoplakia is 
documented for smokers compared to non-smokers, with floor of mouth leukoplakia 
occurring significantly more frequently in smokers (28).  
 
Excessive alcohol consumption has long been recognized as one of the major modifiable risk 
factors for the development of oral cancer (49). Common alcohol serving in the form of beer, 
wine or liquor which contains 10-15 grams of alcohol have been strongly associated with oral 
cancer (18, 50). People who drink three to four alcoholic beverages per day have double the 
oral cancer risk than non-drinkers. Among the individuals who both smoke and drink, a 
synergistic effect has been observed between the latter two with 35-fold increase in oral 
cancer risk compared to those who never drink or smoke (43). Alcohol may influence the 
proliferative cells by increase in carcinogens penetration throughout the oral mucosa. It may 
also exert direct influence on DNA damage and repair mechanisms (51). Alcohol use is one 
of the most important and preventable risk factors for cancer. Studies suggest that up to 75% 




In addition to the known classic risk factors of oral cancer, namely tobacco and alcohol, other 
etiological factors such as infections (bacterial and viral), dietary factors and chemical 
irritants have also been identified (52). Recent publications showed an increased incidence of 
HPV infections in head and neck squamous cell carcinoma (HNSCC) of approximately 50% 
(53). Despite that the role of HPV in OSCC is controversial, some studies detected HPV-16 
in up to 22 percent of oral cancers, and HPV-18 in up to 14 percent of oral cancers cases (48). 
Furthermore, a number of other factors such as UV radiation exposure, chronic traumatic 
factors, poor oral hygiene and immunosuppressive conditions were also associated with the 
oral cancers (54). Geographic/regional variations in the prevalence of oral cancer and 
precancer indicate that the socio-cultural lifestyles of a population play an important role in 
the aetiology and pathogenesis of oral cancers (55). By limiting consumption of tobacco in 
any form and controlling alcohol intake, the risk of oral cancer over the globe can be 
controlled and reduced to a desired level (approximately three-fourth) (16). Evidence 
suggests that smoking cessation interventions are both effective and cost-effective. And the 
involvement of oral health professionals in smoking cessation will help contribute to wider 
tobacco control strategies (56).  
 
1.1.2 Diagnosis of oral cancer  
 
Many oral cancers are found during routine oral examinations. Since it does not usually cause 
symptoms in its early stages, paying attention to changes in the oral cavity is critical, 
especially for people who regularly smoke tobacco and drink alcohol (14, 57). The time lost 
due to delay in treatment seeking is called “the first-time loss”.  The “second-time loss” 
occurs due to lack of awareness among dental professionals and the lack of a timely diagnosis 
(14). Because five-year survival is directly related to stage at diagnosis, prevention and early 
detection efforts have the potential not only for decreasing the incidence, but also for 
improving the survival rate and quality of life for those who develop this disease (48). It is 
important to reduce the “first loss of time” by increasing awareness among people, and to 
shorten the “second loss of time” through education of medical and dental staff (14, 48).  
 
As it was discussed earlier, majority of oral cancers may be preceded by potentially 
detectable mucosal lesions. Thus, thorough examination of the soft and hard tissues within 
the oral cavity becomes very important for early detection of OSCC (23, 58). The diagnostic 
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pathway for oral suspicious lesions usually starts with the conventional oral examination 
(COE) (19, 58, 59). It is based on inspection and palpation of the oral mucosa with the 
support of an incandescent light available on the dental chair. COE mainly depends on a 
subjective interpretation, which is a consequence of the knowledge and experience of the 
operator. However, the criteria for suspicion include changes in surface texture, loss of 
surface integrity, colour, size, contour deviation or mobility of intraoral or extraoral 
structures (19, 59). In 2005 Sankaranarayanan and co-workers in their 9-year screening study 
reported that COE in high-risk patients could prevent about 40,000 deaths from oral cancer 
worldwide (60). While COE may detect a number of clinical lesions and a small percentage 
of those may exhibit histological features of premalignancy, recent data suggests that some 
precancerous lesions may be lurking within mucosa that appears clinically normal by COE 
alone (19). 
 
Further to COE under the normal (incandescent) light, a variety of commercial diagnostic 
aids and adjunctive techniques have been introduced that can assist in the detection of early 
cancerous mucosal changes that can be occult to visual inspection (60). Other clinical 
diagnostic tools for early detection of oral cancer include toluidine blue dye, oral brush 
biopsy kits, salivary diagnostics and most recently, optical imaging systems (61). The gold 
standard for oral cancer diagnosis remains tissue biopsy with histological assessment. 
Biopsies may be obtained using surgical scalpels or biopsy punches and typically are 
performed under local anaesthesia (62). The commonly used incisional and excisional biopsy 
means the removal of a representative sample and the complete removal of the lesion with a 
border of normal tissue respectively (62). However, this technique needs a trained healthcare 
provider, and is considered invasive, painful, expensive and time consuming (61). Vital tissue 
staining with toluidine blue is one of the most-commonly used method for early detection of 
oral premalignant disorders and OSCC. Studies showed that use of toluidine blue in high-risk 
patients examined by experienced providers reduced the number of biopsies of benign lesions 
by approximately 50% (63). It is a useful technique for supplementing clinical judgment (64). 
One alternative to invasive surgical biopsies is also the oral brush biopsy that has been 
intensively assessed in many studies (65). The brush biopsy empowers dentists with a tool 
that can be used to painlessly and accurately evaluate commonly encountered harmless-
looking lesions (66). Furthermore, recent advances in optical imaging systems, such as tissue-
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fluorescence imaging and optical coherence tomography have been proved to be considerably 
efficient (67).  
 
Dentists’ knowledge and education in detecting oral cancer at its precancerous phase is the 
key to prevent its progression to later stages (61). Because more than 90% of all oral cancers 
are OSCCs, the vast majority of oral cancers will be diagnosed from lesions on the mucosal 
surfaces that are accessible and visible during a routine oral examination (62). Unfortunately, 
we continue to diagnose almost 2/3 of these cancers at advanced stages of disease, despite the 
fact that there is an ongoing research for devices/methods to aid the clinicians in detection 
and accurate oral mucosal lesion diagnosis (58). Studies have shown that dentists and other 
health-care providers are in desperate need of systemic educational updates in oral cancer 
prevention and early detection, as they are indolent in the provision of oral examinations and 
in the detection of early oral cancers (58, 61). In order to improve early detection, it is 
imperative to increase the oral health-care professionals depth of knowledge about oral 






Norway, officially the Kingdom of Norway comprises the western and northernmost part of 
Scandinavia in Northern Europe. It lies between latitudes 57º and 81º N, and longitudes 4º 
and 32º E. The country has a total area of 385,207 square kilometres and a population of 
5,374,807 (according to 2020 data). It has an extensive coastline facing the North Atlantic 
Ocean and the Barents Sea, and shares the land border only to the east with Sweden, Finland, 
and Russia. The official language is Norwegian. It is a country encompassing mountains, 
glaciers and deep coastal fjords widely known for fishing, hiking and skiing (68-70). 
 
Norway is richly endowed with natural resources such as oil and gas, fish, forests, and 
minerals. By 1990, Norway was Europe's largest oil producer, and by 1995 it was the world's 
second-largest oil exporter. According to official national estimates, the petroleum sector 
provides about 9% of jobs, 12% of GDP, 13% of the state’s revenue, and 37% of exports. 
The country is strongly integrated to welfare system and has a very high standard of living 
compared with many other European countries. Norway is also a leading producer and the 
world’s second largest exporter of seafood, after China (71, 72). Today, Norway has the 
fourth highest per-capita income in the world on the World Bank and International Monetary 
Fund (IMF) lists. It has GDP per capita of $75,500 (71, 73). According to Statistisk 
Sentralbyrå (Statistics Norway) (SSB) 2020 data, the country has an unemployment rate of 
5.2%, with 68% of the population aged 15–74 employed (74, 75). Presently, the enrolment 
level in secondary and tertiary education amounts to more than two-thirds of the population 
over 16 years old, which makes the Norwegian population one of the most highly educated in 
the world (76). Norway has enjoyed several decades of high gross domestic product (GDP) 
growth, following the start of oil production in early 1970s. GDP per capita rose from NOK 
23 500 in 1970 to NOK 702 000 in 2020. Norway’s GDP is around 81% higher than the 
average among the European Union Member States (76). 
 
1.2.1 The Norwegian healthcare system  
 
History of Norway into the 20th century regarding the financing and organization of the 
healthcare system reflected the fact that the country remained poor, and that the majority of 
the population lived in rural areas. Municipalities and voluntary organizations played an 
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important role as welfare and healthcare providers and the role of the state was limited (76). 
After the Second World War, the organizational structure of the healthcare system changed 
significantly at the state level. While economic growth until the 1970s was just below the 
average, the economy began to rise-up after the discovery of petroleum resources in the 
North Sea. The role of hospitals widened with increasing provision of specialized services 
and a growing provision of ambulatory care services (76). Intersectoral cooperation has 
become increasingly important over the past few years, especially as a means of preventing 
social inequalities in health. More attention has also been paid to improving resource 
allocation, quality issues and patient safety. Health care is organized at three main levels: 
national / state, health regions and municipalities (76, 77).  
 
The organizational structure of the Norwegian health-care system is built on the principle of 
equal access to services for all inhabitants, regardless of their social or economic status and 
geographic location. It is financed by taxation, together with income-related employee and 
employer contributions and out-of-pocket payments (76, 78, 79). Although health care 
expenditure is only 9.4% of Norway’s GDP, given Norway’s very high value of GDP per 
capita, its healthcare expenditure per head is higher than in most countries. Public sources 
account for over 85 % of total health expenditure (76). Out-of-pocket payments account for 
the biggest part of private revenues and made up approximately 14.3 percent of health 
expenditures in 2015 (76). The number of practitioners including physicians and nurses, has 
been increasing in the last few decades and the number of health care personnel per 100,000 
inhabitants is high compared to other EU countries. In 2010 with 407 physicians per 100,000 
inhabitants, Norway had the highest physician coverage among the Nordic countries and also 
compared to the EU average (76).  
 
All residents are covered by the National Insurance Scheme (Folketrygd, NIS), managed by 
the Norwegian health economics administration. In addition to health coverage, the NIS 
finances public retirement funds, sick leave payments, and additional health costs for some 
patient groups (77) . Public health services are delivered at the local and national levels. 
Majority of the hospitals in Norway are public hospitals which are funded and owned by the 
state. A small number of hospitals are privately owned. However, most private hospitals are 
funded by the public. In Norway the state is responsible for hospitals, while the primary 
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health care system is the responsibility of more than 400 municipalities (77). Primary care 
physicians also called regular general practitioners (RGPs) are organized in a list system, to 
which more than 99% of the inhabitants subscribe. RGPs are gate keepers and patients cannot 
decide by themselves to go to a hospital or emergency department. On average, each general 
practitioner cares for approximately 1100 inhabitants (77). 
 
1.2.2 General health status in Norway 
 
Overall, Norway’s population enjoys a good health status compared to other countries. There 
has been a significant decline in mortality from diseases of the circulatory system which has 
been the major cause of deaths in Norway. According to SSB in 2019, life expectancy at birth 
was 81.19 years for male and 84.68 for females (80). Studies have also estimated that the life 
expectancy will continue to increase reaching about 88 for male and 90 years for female in 
2060 (81). During the past decade, the government has launched a number of national public 
health programmes and strategies focusing on risk factors such as smoking, alcohol 
consumption, diet, and physical activity (76, 82). As a result, number of smokers has 
decreased over the last few years. However, several other lifestyle indicators have seen less 
favourable trends. The proportion of people overweight or obese and the consumption of 
alcohol have both increased over past decades. Over the age of 15, per capita alcohol 
consumption in Norway is on average nearly seven litres per year. Male population drinks 
approximately twice as much as females. And social inequalities in health persist despite 
significant improvements in the standard of living of disadvantaged population groups (76, 
82).  
 
The major causes of disability and reduced health among Norwegian population are 
musculoskeletal disorders, mental disorders, cardiovascular diseases, and cancer. Annually, 
nearly 70,000 people are treated in hospitals and out-patient clinics for cardiovascular disease 
and 32,000 new cases of cancer are detected (76, 83). According to the Global Burden of 
Disease (GBD), ischemic heart disease is still the largest cause of both number of deaths and 
Years-of-life-lost (YLLs) in Norway (84). Cancer is the second largest cause of death in the 
population, and the most important cause of death before age 70. Cardiovascular diseases are 
the most important causes of death in the population above 70 years (85). The total burden of 
musculoskeletal disorders and mental disorders is comparable with that of cancer and 
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cardiovascular disease. In total, these four major disease groups represent 65% of the 
Norwegian burden of disease (82).  
 
Musculoskeletal disorders such as pain in the back and neck is also the leading cause of non-
fatal loss of health and the total burden of disease in Norway. It is probably the most common 
reason for patients visiting their general practitioner. According to the health surveys in 
Trøndelag and Tromsø, approximately 50% cases of disability benefits can be attributed to 
chronic musculoskeletal pain (76, 82, 86). Mental disorders are the greatest cause of loss of 
health among children, young people, and adults of working age. The most common 
disorders are anxiety, depression, and substance use disorders. In any year, about 1 in 5 adults 
(approximately 16–22%) will be affected by a mental disorder (76, 82, 87). And around 6% 
of the population take antidepressants (87). Each year, approximately 40,000 individuals are 
treated by the specialist health service for heart attack and angina, 16,000 for heart failure and 
11,000 for stroke. Around 1.1 million Norwegians use therapeutic drugs to either prevent or 
treat cardiovascular disease. And these numbers are further projected to rise in the future. 
Cardiovascular disease, cancer, chronic obstructive pulmonary disease (COPD) and diabetes 
are responsible for two in three deaths as well as a high proportion of consultations in the 
health service (82, 88).  
 
According to the Cancer Registry of Norway in 2018, total number of 34,190 new cancer 
cases were reported. The vast majority of cancers in Norway are diagnosed among people 
aged 50 years or more (89). Prostate cancer continued to be the leading site for cancer 
incidence in men, whereas breast cancer was the most frequent cancer site in women. In both 
gender, lung and colon cancer rank second and third. Registry also estimated that one in three 
Norwegians will develop a cancer before the age of 75 (89).  
 
1.2.3 The oral healthcare in Norway  
 
Oral healthcare in Norway is divided into the public and the private oral health services. The 
Public Dental Health Service (PDHS) is organised and funded by the counties. It is carried 
out by salaried dentists in dental clinics operated by the counties, also in cooperation with the 
municipalities (76, 90, 91). According to the Norwegian Dental Association (NDA) 2019 
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report, around 25% of the total dentists were associated with the PDHS (92). All the oral 
healthcare services and treatment are provided free of charge for children and young people 
aged 0–18 years, except for orthodontic treatment. However, young people aged 19–20 years 
must pay 25% of the total costs of treatment fees, set by the ministry of health and care 
services. Mentally disabled persons, children (upto18years), groups of elderly and people 
with a long-term illness living either in institutions or receiving care at home are priority 
groups and can access public dental care services for free of charge or pay reduced fees. 
PDHS may also be accessed by people that do not belong to these group, but only after the 
treatment needs of the priority groups has been fulfilled (76, 90, 91, 93). Annually between 
60% and 76% of the population in the priority groups receive screening and/or treatment and 
about 10% of the non-priority group adults also receive care from the PDHS (90).  
 
Oral healthcare for adults 20 years and older is provided at private dental healthcare services, 
both in terms of provision and financing. Around 75% of dentists work as private 
practitioners according to NDA in 2019. Fees for most treatments are usually paid in full out 
of the patient’s pocket (76, 90, 92, 93). Standards in oral health practices are monitored by 
the County Medical Officers through designated dentists who supervise and assess the 
observance of dental standards and quality assurance programmes (76). Specialist healthcare 
services, public dental health services and municipal health and care services are all built on 
the same fundamental values (94). According to the NDA 2019 report, the total registered 
number of dentist was 6,777 (92). The estimated dentist to population ratio was 1 to 783 and 
total of 0.41% GDP was spent on oral health in 2005 (90).   
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1.2.4 Education and training of oral health professionals 
 
To be eligible to enter dental school in Norway, applicants must have a general matriculation 
standard. This means completed higher secondary school, with mandatory advanced courses 
in mathematics, physics and chemistry (90). Education and training of dentists takes places in 
three dental institutions in Norway: University of Bergen (UiB), University of Oslo (UiO) 
and The Arctic University of Norway (UiT) (95, 96). Due to decreasing dental workforce in 
the country, a new dental school in Tromsø was established in 2004. At the UiB and UiT, 
there is a joint Faculty for Medicine and Odontology whereas UiO has a separate Faculty for 
Odontology responsible for the education of the dentists (90). The study duration is total of 5 
years, with 3rd, 4th and 5th year being the clinical years when the students are allowed to 
imply their knowledge and practices on their patients. Master of dentistry (dental surgeon) 
program covers the study, diagnosis, prevention, and treatment of diseases, disorders and 
conditions of the oral cavity (96, 97). All the graduates after the completion of study, are 
required to register with the Norwegian Registration Authority for Health Personnel. After 
the age of 75 years, dentist's registration can only be renewed if the practitioner is considered 
fit to continue the practice (90). 
 
There is an organized full-time postgraduate training period for specialists at the universities 
in Norway. There are seven recognised dental specialities: oral surgery and oral medicine, 
endodontics, orthodontics, oral radiology, paediatric dentistry, periodontics, and 
prosthodontics. The first six specialties are three-year studies and oral surgery, and oral 
medicine is a five-year course. All postgraduate specialist training is free of charge (90, 93). 
The universities in Oslo and Bergen run the programmes for graduate dentists who want to 
achieve authorisation as a specialist. Large number of dentists (one-quarter) are qualified 
outside Norway. Dentists qualified in other EEA states are automatically qualified and may 
practice in Norway (90, 96), whereas, dentists having a dental degree from a country outside 
the EU/EEA need to go through the qualification program. This is a fulltime study with a 
duration of 1.5 years, with mostly clinical and theoretical instructions. The aim of the 
program secures the professional qualifications of the foreign dentists and gives them a basic 




1.2.5 Oral health status in Norway 
 
Since the 1970s, children and adolescents have grown up with fluoride toothpaste and a 
systematic dental health service from the PDHS in Norway. There has been a significant 
improvement in the oral health status of the population during the last 35-40 years (99). The 
overall oral health is relatively good and the share of the population who visit a dentist/dental 
hygienist every year is high when compared internationally (96, 100). However, dental health 
still varies with age, economy, location and belonging to vulnerable groups. Clinics in the 
public dental services are responsible to send annual reports to the county about the dental 
health of 5, 12 and 18-year-olds (99). Dental health among children varies widely between 
cities, districts and counties whereas dental health among adults varies with education and 
socio-economic status (99). 
 
The dental health of young children and adolescents has improved significantly over the past 
few decades in Norway. The young children are supposed to be examined in children’s 
healthcare clinics at 2 years of age for possible referral to a dentist (96). According to the 
data reported by SSB in 2018, the proportion of 5-year-olds without decayed, missing, or 
filled teeth (DMFT = 0 percent) was 81.3% in 2018, while the corresponding figure for 12-
year-olds was 60.4%, and the share of 18 years old patients with DMFT 0 percent was 
reported to be 26.7% (101). The dental health of 18-20-year-olds has also improved sharply 
in recent decades. Results from examinations of young adult 18-20-year-olds in the armed 
forces showed that about 27% have never had cavities in 2018 (99). In Norway, children with 
immigrant background seem to have more dental caries than children with a Norwegian 
background. Around 60% of 3-year-olds with an immigrant background had no caries 
compared to 84% of 3 year-olds with a Norwegian background (96, 99). A survey on adult 
dental health in 2015 suggested that as many as 76% evaluated their dental health as good or 
very good (99). Adults with severe periodontal disease have decreased from 21.8% in 1984 to 
8.1% in 2003 (96). Majority of the elderly population visit the dentist on a regular basis 
compared to the younger adults. The incidence of tooth loss in the elderly Norwegian 
population is decreasing. A study performed in 2003 on the prevalence of teeth and dentures 
among individuals aged 67 and above reported that 40% had their own teeth only, 28% had a 




1.2.6 Oral cancer in Norway 
 
According to the latest WHO data published in 2018, oral cancer deaths in Norway reached 
156 or 0.46% of total deaths. The age adjusted death rate was 1.65 per 100,000 of population 
ranks Norway #161 in the world (102). There are few more than 600 new cases of oral cancer 
every year. A total of 400 men and 237 women were diagnosed with cancer of the oral cavity 
and upper part of the throat in 2016 (103). Results from the NORDCAN database reported 
that the incidence of oral cancer in the Nordic countries has been increasing over the last ten 
years. The majority of OSCCs are to be found in older age groups, most frequently in the 
sixth to seventh decades of life (104). Tobacco and snuff use over a long period of time along 
with high alcohol consumption is strongly associated with the increased risk of oral cancer 
(105). In recent years, researchers have also discovered a significant increase in the incidence 
of HPV infection in the oropharyngeal cancers (103, 104). According to the cancer registry of 
Norway 2018, the number of new cases of cancer in the oral cavity from the year 2009 to 
2018 suggests that the cases have increased from 113 to 136 for males and 73 to 108 for 
females respectively (89). Overall five-year survival rate for the patients with localized 
disease has remained unchanged between 70% and 90% for over the past 40 years in 
Norway. During the same period, the prognosis for those with lymph node metastasis has 
improved from 20% to 50%, and distant metastasis has changed from 15% to 4% (89). 
Norwegian cancer registry also suggests that the oral cancer often presents with regional 
stage of metastasis at the time of diagnosis which poses difficulty in the treatment of oral 
cancer efficiently (89).  
 
2.0 Rationale of the study  
 
Oral diseases are one of the emerging mainstreams in global health. Poor oral health has a 
profound impact on the general health, and affects both the wellbeing and quality of life 
(106). Despite great achievements in the oral health of populations globally, problems still 
remain in many communities around the world (15). Oral diseases prevention and oral health 
promotion are a widely neglected area in public health. Regarding oral cancer there is 
evidence that the visual examination as part of a population screening program reduces 
mortality in patients at high risk (15). Early diagnosis and treatment remain to be the key to 
improving survival of patients. Hence the major goal is to focus on preventive measures at 
the first place so that mortality due to oral cancer is reduced and is in control (20). The 
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overall 5-year survival rate tends to diminish if the diagnosis is made at the late stage of oral 
cancer. The survival rate of 70% to 90% can be achieved if the diagnosis is made at the early 
stage (89). Clinical manifestations and effects of treatment can lead to negative impact on the 
quality of life. Patients who survive the late stage of cancer may experience significant 
dysfunctions in talking, swallowing, alteration of cosmetic appearance, sensory impairment 
and negative psychological impact (107).  
 
Oral cancers are among the most common preventable non-communicable diseases and 
dental professionals play an important role in the prevention of oral cancers and oral health 
promotion (106). For the treatment and counselling of the patients regarding oral cancer, 
dentists need a profound knowledge over disease aetiology and progression and the possible 
impact of lifestyle factors as well as of therapeutics and pharmacology (100). Since majority 
of oral cancers are preceded by the precancerous lesions on the oral mucosa, the dentist must 
be familiar with the normal variation in tissues of the oral cavity and perform visual oral 
examination in the patients. Furthermore, the dentist must be aware of diseases demanding 
multi-disciplinary cooperation and be able to recognize their professional limitation, and to 
refer to other specialists when required (30, 100). Teaching curriculum at dental teaching 
institutions in Norway covers extensively lesions with malignant potential and oral cancer 
prevention and management. Dentists in Scandinavian countries, including Norway, are 
taught and trained to either take a biopsy or refer to an oral surgeon when they observe an 
oral potentially malignant lesion or an early OSCC lesion. Prevention of oral cancer and 
mucosal examination has been included in the curriculum of dental studies (97, 100). 
Similarly, in Norway majority of the patients consult their general dentist on regular (yearly) 
basis for the oral check-ups (100). This provides the dentists with a unique opportunity to 
make an early diagnosis of oral diseases, which is beneficial for both the patient and the 
society. Despite that, approximately 50% of patients are diagnosed at the dental clinics in the 
late stage oral cancer in Norway (89).  
 
The oral health professionals hold an important responsibility in the prevention and control of 
oral cancer and the early diagnosis highly depends on their knowledge (108). The 
understanding and evaluation of attitudes and awareness of dental healthcare professionals is 
vital in assessing their effectiveness in the prevention and early detection of oral cancers 
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(108). Findings from this study will reveal the level of knowledge, the attitudes and practices 
related to prevention of oral cancer and oral mucosal examination among dentists. This will 
serve as basis to inform future policy initiatives aiming to further develop and improve the 





3.0 Aims  
 
3.1 The overall aim 
The overall aim of this study was to investigate knowledge, attitudes and practices related to 
oral cancer prevention and oral mucosal examination among dentists in Norway.  
3.2 Specific objectives 
 
• To evaluate the level of knowledge on oral cancer risk factors, early symptoms, and 
diagnostic signs among dentists in Norway. 
• To assess dentists’ attitudes towards risky behaviours, oral mucosal screening, and oral 
cancer prevention in Norway. 
• To assess the relationship between the level of knowledge and socio-demographic 
characteristics.  
• To evaluate practices related to oral cancer prevention and oral mucosal examination for 
early detection.  
• To assess the perceived barriers to perform oral mucosal examination.  
• To assess dentists’ self-care behaviour towards tobacco usage and links between certain 
behaviour influence on practices in providing counselling to the patients concerning 
main risk factors for oral cancer. 
4.0 Methodology  
 
The study is part of the Oral Pathology Collaboration Project, financed by Norwegian Centre 
for International Cooperation in Education (CPEA-LT-2016/10106). This project aims at 
establishing a joint standardized oral pathology teaching curriculum aligned between the 
collaborative institutions and to initiate common research activities in this field (109). This 
study was carried out during the period from Autumn 2020 until Spring 2021.   
 
Similar studies have been carried out in the Eurasian countries Moldova, Belarus, and 
Armenia. The project has been further expanded to map the level of knowledge, attitudes, and 
practices regarding preventive dentistry in the countries in the East African region such as 
Tanzania, Ethiopia and Uganda.  
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4.1 Study area  
 
The present study was conducted in Norway. National language in Norway is named 
Norwegian. The language has two official written forms, Bokmål, and Nynorsk. Around 95% 
of the population speak Norwegian as their first or native language (110). As a result of a 
significant increase in the proportion of population over the age of 80 years, the population of 
Norway continued to grow slowly but steadily at the end of the 20th century. Both the birth 
and death rate fell slightly during the 1990s to about half the world’s average. The life-
expectancy has been among the highest in Europe since then. Presently, Norway is among 
one of the wealthiest nation and maintains the Nordic welfare model with universal health 
care and a comprehensive social security system (111).  
 
Norway has both administrative and political subdivisions on two levels: counties and 
municipalities. The country has total of 11 counties which form the first-level administrative 
divisions of Norway and are further subdivided into 356 municipalities (112). The county 
Østlandet contains more than half of Norway’s population, most of whom live in the 
metropolitan area of the national capital Oslo (113). Dental services in Norway are broadly 
categorized into public and private dental services. The Public Dental Health Service (PDHS) 
is organised on a county basis. In 2014, measured by gross operating expenditure, the 
counties spent a total of NOK 3.3 billion on public dental care. This corresponds to a 7 per 
cent increase in expenditure from 2013 and approximately 20 per cent increase in expenditure 
from 2010 to 2014 (114).  
 
4.2 Study design and study population  
 
The study was a cross-sectional survey based on an electronically administered questionnaire 
to assess preventive knowledge, oral health related behaviours and practices of oral cancer 
prevention and oral mucosal screening among dentists in Norway.  
Study population comprised all the practicing dentists currently employed in the Public 




4.3 Survey instrument and questionnaire  
 
A structured questionnaire for the dentists was constructed based on previous literature and 
the studies conducted previously as part of the oral pathology collaboration project, financed 
by Norwegian Centre for International Cooperation in Education (CPEA-LT-2016/10106). 
The questionnaire was used to collect socio-demographic characteristics, information about 
the oral mucosa examination, knowledge regarding oral cancer preventive procedures, their 
own practices regarding risky behaviours for oral cancer, and attitudes towards oral mucosal 
screening. To ensure confidentiality and anonymity and minimize response bias due to social 
desirability, respondents name or identification on the questionnaires were not included.  
The original questionnaire was constructed in English and was translated into Norwegian 
language. In December 2020, 10 dentists from the UiB have participated in the pretesting of 
the survey. Based on pre-test results and the opinion of the academicians, necessary changes 
were made.  
The final questionnaire consisted of 47 questions. Questionnaire was constructed based on 
sections such as: personal data, competency and orientation in preventive care, preventive 
knowledge, preventive practice for patients, oral mucosal screening, and oral cancer 
prevention.  
 
4.4 Variables and measures of the questionnaire  
Socio-demographic characteristics were assessed in terms of age, gender and working years 
as dentist. The age of respondents was recorded and categorized as (1) 23-30 years, (2) 31-40 
years, (3) 41-50 years, and (4) 50+ years. Respondent’s sex was coded as (1) female, (2) male 
and (3) others. The participants were asked how long they have been working as dentist. 
Working years of dentists (work experience) were categorized as (1) 0-10 years, (2) 11- 20 
years, (3) 21-30 years, and (4) 31+ years. The place of completion of the basic degree of 
dentistry for dentists was coded as (1) Norway and (2) abroad. Dentists practice 
characteristics were assessed in terms of type of practice and coded as (1) solo and (2) non-
solo. Specialty/special competence was recoded as (1) general dentistry, (2) paediatric 
dentistry/orthodontics, (3) restorative/endodontics, (4) periodontics, (5) prosthodontics, (6) 
oral surgery and (7) oral pathology.  
33 
 
Questions 25-30 and 36-38 were used to explore the dentists’ knowledge about risk factors, 
lesions with premalignant potential, risk sites and clinical properties of early cancer lesions. 
Questions about risk factors to oral cancer were coded as (1) yes, (2) no and (3) do not know. 
Questions about lesions with malignant potential were coded as (1) Morbus Chron, (2) 
Erythroplakia, (3) Blue nevus, (4) Leukoplakia, (5) Aphte and (6) Do not know. Questions 
about the most common sites for oral cancer were coded as (1) all sites equally, (2) floor of 
the mouth, (3) buccal/lip mucosa, (4) hard palate, (5) soft palate, (6) retromolar 
region/palatopharyngeal arches, (7) tongue, (8) rim (sides) of tongue and (9) Do not know. 
Questions about properties of early cancer lesions were coded as (1) small, painless white 
area, (2) small, painless red area, (3) small, painless, indurated ulceration, (4) small, painful, 
indurated ulceration and (5) do not know. Questions (25-30) were used to assess dentists' 
level of knowledge regarding oral cancer risk factors. For each correct answer on questions, a 
score of “1” was given. For the questions regarding common sites for oral cancer (Q36), a 
score of “3” was given to responders choosing all the correct options: the floor of the mouth; 
tongue and rim of tongue. Similarly, score of “2” was given for electing two correct options 
and score of “1” for choosing one of them. Regarding the question about lesions with 
malignant potential (Q37), a score of “2” was given to respondents choosing leukoplakia and 
erythroplakia, and a score of “1” for electing one of them. On the question about clinical 
properties of an early cancer lesion (Q38) score of “3” was given for choosing all correct 
options: small, painless, indurated ulceration; small, painless white area; small, painless red 
area; a score of “2” was given for electing two of them and score of “1” for choosing one of 
them. Dentists' level of knowledge was constructed based on the total number of points 
accumulated (ranging from 0 to 14). Knowledge score was dichotomized into 0= lower score 
of knowledge (0-9), and 1=higher score of knowledge based on the mean (10-14). 
Questions (7-14 and 39-41) were used to assess practices related to oral mucosal screening 
and oral cancer prevention, with response coded as (1) yes, (2) no and (3) do not remember. 
Questions 8 and 10 were used to assess practices related to oral mucosal screening on all new 
and recall patients. Respondents had allowance to choose more than one option with the 
response coded as (1) children under 20, (2) 20-60, and (3) over 60. 
Opinions regarding oral mucosal examination and referral for oral mucosal pathology were 
assessed by questions 15-19 and 42-45. Responses were coded on a scale ranging from (1) 
strongly disagree to (5) strongly agree. 
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Questions 20-24 were used to identify barriers regarding oral mucosal examination. Answers 




4.5 Data collection and measurements  
 
4.5.1 Recruitment and data collection from the dentists 
Recruitment of dental health care workers was facilitated through the County Dental Officers 
(fylkestannlegen) in each of the Norwegian counties. This ensured our access to updated lists 
of employees in the PDHC in Norway. The data collection among dentists was conducted 
during December 2020 to April 2021. Initially detailed information about the study was sent 
to all potential participants through e-mail. After one week, invitation to participate in the 
survey and informed consent was sent together with a link to an electronic questionnaire 
administered through the internet-based platform MachForm system at University of Bergen 
skjemaker.app.uib.no. Participants were asked to tick-off for the informed consent to be 
registered as participants in the study, and no data collection started before the informed 
consent has been signed. E-mail with information about the study as well as e-mail with 
invitation letter and link to the questionnaire was administered by the project leaders at 
University of Bergen. Exclusion criteria were dentists who did not consent to participate in 
the study.  
4.5.2 Recruitment plan for dentists  
 
 




Ask county dentists (Fylkestannlegen) to send e-
mails of dentists employed in the PDHC
Information letter
Send information letter about the survey to 
Fylkestannlegen 2-3 weeks before the start
Fylkestannlegen distribute the information letter to the 
corresponding dental workers by e-mail
Dental workers reserve time to fill the questionnaire 
for 30 min
Study start
Project leader sends the invitation to survey to all 
dental workers
Reminder Project leader sends reminders 
Report Project leader sends a report to Fylkestannlegen 
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4.6 Data management  
 
All the completed questionnaires were coded with a number (merging key Koblingsnøkkel). 
It was not possible to link completed questionnaires to e-mail addresses or any other personal 
data through the MachForm system at University of Bergen skjemaker.app.uib.no. The data 
collection was voluntary and anonym. Information from this study were stored and managed 
confidentially at the Department of Clinical Medicine at the University of Bergen. Data sets 
were stored appropriately according to the rules and regulations and made available for 
analysis with the statistical software of STATA and SPSS. Strict back-up procedures at the 
data management center have been established.  
 
4.7 Statistical methods  
All the data obtained from the survey were manually entered into Excel-file. Analyses were 
performed using IBM SPSS Statistics version 25 (IBM Corporation, NY, USA). Figures and 
tables were designed in Microsoft Excel. Descriptive analyses in terms of frequency of 
distributions were performed on all variables. Chi-square tests were employed to assess 
bivariate relationships. Dichotomization of the knowledge score into low and high score 
(based on the mean) was carried out to find association between the knowledge score and 
socio-demographic characteristics and practice characteristics. The level of statistical 
significance was set at 5%. 
 
4.8 Ethical consideration  
 
The project was registered in Norway at the Norwegian Centre for Research Data (NSD) 
(Project No: 166995). The study was performed according to the Helsinki Declaration. The 
questionnaire was anonymous, and participation was voluntarily. The participants of the 
study received written and verbal information. Before enrolment, a signed written consent 
was gathered from all participants prior to participation. The participants were free to 





5.0 Results  
 
5.1 Response rate and sample profile  
 
A total of 280 dentists participated in the study. The overall response rate was 23.7% 
(280/1178). The mean ± standard deviation (SD) age of dentists was 40.5 ± 10.19. 
 
The distribution of men and women was 19.3% and 80.7%, respectively. The mean ± 
standard deviation (SD) years of experience as a dentist was 13.8 ± 9.98. However, 47.8% 
(134) reported 0-10 years of experience followed by 27.9% (81) who reported 11-20 years of 
experience. Only 8.2% (24) of dentists answered that they worked solo. A total of 26.3% (74) 
dentists had gotten their basic degree abroad. Majority of the dentists (96.3%) reported 
specialty as general dentistry while only 0.4% (1) dentists reported speciality as endodontics 
and periodontics. Around 1.9% and 1.1% of the respondents also reported their speciality as 






































5.2 Assessment of knowledge on oral cancer prevention and early 
detection  
 
Tobacco and prior oral cancer lesions were identified as the main risk factors by majority of 
the dentists (Figure 4). Abusive use of alcohol and older age as risk factor scored also 
relatively high, 87.1% and 81.9% respectively. Total of 69.4% respondents also identified 
viral infection with HPV as risk factor. However, low consumption of fruit and vegetables 
scored the lowest with only 16.1% considering it as risk factor (Figure 4). 
 
 
Figure 4. Knowledge about oral cancer risk factors (n=280) 
 
The site listed most often as one of the common sites for oral cancer was the rim of tongue at 
68.2%, followed by floor of the mouth at 60.7% and tongue at 37.5%. Except for the sites 
mentioned above, buccal/lip mucosa scored relatively high at 35%. Erythroplakia was 
considered the most common lesion with malignant potential by majority of dentists at 
83.2%, leukoplakia being listed as the second lesion most likely to become malignant at 
80.4%. The most-commonly listed clinical properties of early cancer lesions were “small, 
painless, indurated ulceration” and “small, painless red area” at 73.6% and 46.4% 
respectively. Only 31.4% of the respondents identified “small, painless white area” as 
common clinical properties of early oral cancer (Table 4).  
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Table 4. Knowledge about lesions with malignant potential, risk sites and clinical properties 
of early cancer lesions (n=280) 
 
 
The majority of the respondents (95.4%) listed undergraduate courses as the major source 
from where they got their information on oral mucosal screening and oral cancer prevention. 
Postgraduate courses and scientific journals were listed as common sources by 37.9% and 
31.8%, respectively. However, only 28.2% listed textbooks as a source of information 




Most common sites for oral cancer
All sites equally 5.4(15)




Retromolar region/palatopharyngeal arches 16.8(47)
Tongue 37.5(105)
Rim of tongue 68.2(191)
Do not know 12.1(34)






Do not know 6.8(19)
Clinical properties of an early cancer lesion
Small, painless white area 31.4(88)
Small, painless red area 46.4(130)
Small, painless, indurated ulceration 73.6(206)
Small, painful, undurated ulceration 21.1(59)
Do not know 6.1(17)
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Figure 5. Number of responses regarding the source of information about oral mucosal 
screening and oral cancer prevention (n=280)  
 
 
The mean ± standard deviation (SD) knowledge score was 9.2 ± 2.2. Total of 52.3% of the 
respondents had higher score for knowledge (range 0-14). A total of 79.5% of the female and 
20.5% of the male dentists had higher knowledge score. However, there was no statistically 
significant association found between higher knowledge score and socio-demographic or 











under 40 years 59.4(76)






more that 10 years 54.2(78) 0.489








5.3 Assessment of practices related to oral cancer prevention and 
early detection  
 
The majority of dentists reported that they check all new patients for oral mucosal lesions 
(83.3%), while checking all recall patients scored slightly less (77.7%). Majority of the 
respondents also reported that they ask patients about current/previous use of tobacco with a 
high score of 84.5%. Only 12.6% of respondents reported that they ask patients about 
current/previous use of alcohol. Total of 11.5% respondents only reported to ask their 
patients about family history of oral cancer. The majority also answered that they were giving 
counselling to the patients regarding tobacco cessation quite often/always or almost always, 
while the percentage of dentists who were mentioning giving counselling to the patients 










Do you check all new patients for oral mucosal lesions?
Yes 83.3(232)
No 11.5(32)
Do not remember 5.4(15)
Do you check all recall patients for oral mucosal lesions?
Yes 77.7(217)
No 12.1(34)
Do not remember 10.4(29)
Do you ask patients about current/previous use of tobacco?
Yes 84.5(234)
No 7.2(20)
Do not remember 8.2(23)
Do you ask patients about family history of oral cancer?
Yes 11.5(32)
No 74.1(206)
Do not remember 14.4(40)
Do you ask patients about current/previous use of alcohol?
Yes 12.6(35)
No 72.7(202)
Do not remember 14.7(41)
Do you give counselling to your patients regarding tobacco cessation?
Not at all 0.4(1)
Seldom 13.8(38)
Quite often 51.8(143)
Always or almost always 34.1(94)
Do you give counselling to your patients regarding excessive alcohol cessation?
Not at all 26.2(73)
Seldom 62.4(174)
Quite often 8.2(23)
Always or almost always 3.2(9)
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A total of 79.6% respondents had previously detected a suspicious lesion for oral cancer. 
Approximately equal number of respondents (79.1%) also had referred to a specialist for a 
suspicious lesion for oral cancer. Around 48.6% reported to have referred oral surgeon 
specialist (not shown in the table), whereas only 43.4% reported that they had ever performed 
a biopsy of oral mucosa (Table 7).  
 
Table 7. Dentists’ practices when detecting a suspicious lesion (n=280)  
 
 
Majority of the dentists who agreed upon the opinion that the dentists should perform oral 
mucosal examination, were in practice performing the examination on all new patients 
(85%). Chi-square test after dichotomization of variables reveals statistically significant 
correlation between opinion that the dentist should perform examination of oral mucosa and 
the practices related to performing examination of oral mucosa on all new patients (p<0.05). 
There was found no statistically significant correlation observed with regards to the recall 




Detected suspicious lesions for oral cancer
Yes 79.6(222)
No 16.8(47)




Do not remember 2.9(8)
Performed biopsy of oral mucosa
Yes 43.7(122)
No 55.6(155)
Do not remember 0.7(2)
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Table 8. Dentists that should perform oral mucosal examination compared to dentists who 
were in practice performing examination of oral mucosa on all new and recall patients. Chi-
square test.  
 
 
5.4 Assessment of opinions towards oral mucosal screening and 
oral cancer prevention  
 
Majority of respondents strongly agreed that the dentists should perform examination of oral 
mucosa on all new and recall patients, 86.4% and 84.9% respectively. A vast majority of the 
dentists also strongly agreed that it is the role of dental hygienists to perform oral mucosal 
screening on both the new and recall patients at 84.8% and 83% respectively (Table 7). 
Around 24.1% of the respondents also agreed that it is the role of medical doctors, family 
doctors, or specialists to perform oral mucosal screening. A total of 61.6% of the dentists 
agreed that they can influence a patient to reduce/quit smoking or drinking alcohol. Similarly, 
62.2% respondents also agreed that it is the role of the dentists to provide smoking or alcohol 




Dentists who agree with the opinion are in practice performing oral 
mucosal examination on all new patients 85.0(232)
Dentists who agree with the opinion but do not perform oral mucosal 
examination on all new patients 15.0(41) <0.001
Dentists who agree with the opinion are in practice performing oral 
mucosal examination on all recall patients 78.0(216)
Dentists who agree with the opinion but do not perform oral mucosal 
examination on all recall patients 22.0(61) 0.223
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Dentists should perform examination of oral mucosa on all new patients
Disagree 0.7(2)
Do not know 1.1(3)
Agree 11.8(33)
Strongly agree 86.4(241)
Dental hygienists should perform examination of oral mucosa on all new patients
Disagree 0.7(2)
Do not know 1.1(3)
Agree 13.4(37)
Strongly agree 84.8(235)








It is the role of medical doctors, family doctor, specialists to perform oral mucosal screening
Strongly disagree 8.6(24)
Disagree 37.5(105)
Do not know 23.4(65)
Agree 24.1(67)
Strongly agree 6.1(17)
You in current role as a dentist can influence a patient to reduce/quit smoking or drinking alcohol
Disagree 4.7(13)
Do not know 23.3(65)
Agree 61.6(172)
Strongly agree 10.4(29)
You in current role as a dentist should provide smoking or alcohol cessation advice
Disagree 0.7(2)





5.5 Assessment of behaviours towards tobacco use  
 
The majority of the respondents reported that they never smoked cigarettes/pipe, electronic 
cigarettes and snuff or chewing smokeless tobacco. However, small number of respondents 
(5%) reported to use snuff or chewing smokeless tobacco everyday (Table 10). 
 
Table 10. Frequency distribution of tobacco use (n=280)  
 
 
Chi-square test investigating the relationship between the respondents who were asking 
patients about current/previous tobacco and alcohol use, and counselling patients regarding 
this was performed. There were statistically significance association found with regards to 
asking patients about current/previous tobacco and alcohol use and giving counselling to the 
patients regarding cessation (Table 11). Dentists who asked patients about the tobacco and 
alcohol use, tended to give counselling more than the dentists who does not ask patients 
regarding this. There was found no statistically significant association between the smokers 
and non-smokers who were giving counselling to their patients regarding tobacco cessation 
(not shown in the table).   
Variables % (n)
How often do you smoke cigarettes/pipe?
Every day 0.4(1)
Several times a week 0.4(1)
Several times a month 0.7(2)
Seldom 2.9(8)
Smoked but quit 5.7(16)
Never smoked 90.0(251)
How often do you smoke electronic cigarettes
Smoked but quit 0.4(1)
Never smoked 99.6(277)
How often do you use snuff or chewing smokeless tobacco
Every day 5.0(14)
Several times a week 1.4(4)
Once a week 0.4(1)
Several times a month 0.7(2)
Seldom 4.0(11)




Table 11. Dentists who were counselling and not counselling patients who were using 





Dentist who ask about current/previous use of tobacco and give 
counselling  regarding tobacco cessation 89.7(208)
Dentist who ask about current/previous use of tobacco but do not give 
counselling  regarding tobacco cessation 10.3(24) <0.001
Dentist who ask about current/previous use of alcohol and give 
counselling regarding alcohol cessation 54.3(19)
Dentist who ask about current/previous use of alcohol but do not give 
counselling  regarding alcohol cessation 45.7(16) <0.001
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5.6 Perceived barriers to perform oral mucosal screening  
 
The most common listed barriers to perform oral mucosal screening were reported to be lack 
of experience and lack of training (36% and 34.9%, respectively). However, the opinion on 
lack of experience as a barrier was split relatively evenly, as 32.4% also disagreed that this 
was a barrier. Lack of knowledge was also listed by a relatively high number of the 
respondents (28.4%). Majority of the respondents do not consider lack of clinical time and 
financial incentives as perceived barriers to perform oral mucosal examination (Figure 6).  
 





















6.0 Discussion  
 
6.1 Discussion of methodology  
With regards to the key strength of the study, it is important to note that this is the first cross-
sectional study focusing on assessing knowledge, opinions and practices related to oral 
cancer prevention and oral mucosal examination among dentists in Norway. Secondly, we 
aimed to include all the dentists working in all the public dental health services in the 
country. The response rate at 23.7% for dentists was lower compared to the several other 
studies (115-119). When looking at the similar studies, the response rate varies between 16% 
and 92% (117, 118, 120, 121). According to the guidelines from the British Journal of public 
health dentistry, response rates should be above 55 % to be considered acceptable (122). A 
lower response rate can increase non-sampling error and can also be used as an indication of 
the quality of the study. However, non-response error or bias is not only dependent on the 
number of non-responses, but also the extent of differences between responders and non-
responders (122). One of the reasons for non-responses may be lack of time and 
prioritization. Challenges brought up by the current Coronavirus disease (COVID-19) 
pandemic in the country could possibly also be another reason for non-participation in the 
study. 
Just as in many other surveys, the following study also has some limitations. In order to make 
a valid conclusion, limitations as well as possible bias must be taken into consideration (123). 
The length of the questionnaire may be considered as one of the major limitations of the 
present study, as it consisted of a total of 47 items. This may have been interpreted as 
burdensome and could have been a reason for reluctance to participate to the study.  
External validity evaluates if the results from a study can be generalized to other settings 
(124). When assessing the external validity in this study it is important to notice that this 
study was restricted to the dentists working in the public dental services. It might therefore be 
difficult to translate these findings to the private dental services of the country because of 
obvious differences in type and availability of clinics as well as access to other healthcare 
facilities, and majority of the dentists works in the private dental services in Norway (90). 
Low response rate for the study may have led to non-response error or bias, which again may 
have led to bias in the result interpretation, as it is assumed that respondents are more likely 
to be interested in the topic compared to non-respondents. However, we believe that the 
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extent of differences between responders and non-responders in our study is narrower, given 
broad representation and high coverage. 
When assessing the internal validity, one may look at recall bias and social desirability bias. 
The study was based on a self-administered questionnaire, and potential biases caused by 
self-reporting must not be excluded. Social desirability bias implies that respondents may not 
have been entirely truthful in their answers, which may have led to over-reporting of socially 
favourably behaviours and attitudes or under-reporting of undesirable behaviour (125). To 
minimize this type of bias, anonymous questionnaires were used in the present study. Recall 
bias is another type of bias which can arise from the cross-sectional studies (126). When 
respondents were asked questions what they recall might not be accurate due to several 
factors such as time since the event and personal characteristics (123, 126). This is 
particularly true when the questions are either private or sensitive or if the anonymity and 
confidentiality of the study is not guaranteed. Therefore, biases mentioned above, must be 
taken into consideration when interpreting the results.  
All kind of health research are subjected to bias in various forms (123). In order to make 
valid conclusions from a study one must therefore identify these biases and the impact they 
may have on the final results (123, 127). Despite that, strength of this study encompasses 
being the first of its kind in the country and could lead to further research being conducted in 





6.2 Discussion of the results  
 
6.2.1 Knowledge on of oral cancer prevention and early detection  
 
Oral cancer risk factors  
Tobacco was correctly identified as a risk factor for oral cancer by more than 97.8% of 
respondents, followed by prior oral cancer lesions (93.5%). Similar results have been 
observed in the studies conducted previously in other countries (116, 121, 128-130). While 
alcohol still was considered a risk factor by the majority (87.1%), the percentage of 
respondents who reported abusive use of alcohol as a risk factor was lower compared to other 
studies conducted in the USA (95%), Spain (96.4%), and Australia (94.6%) (128, 130, 131). 
Whereas, the result in the present study was higher compared to the similar study conducted 
in Eurasia (Moldova (69.7%), Belarus (66%) and Armenia (50%)) (132). Several studies 
conducted in non-smoking groups revealed a strong association between abusive use of 
alcohol and oral and pharyngeal cancer (133-135). Findings from these studies infer the 
importance of dental practitioners’ awareness on abusive alcohol use as a risk factor, 
particularly in the countries with high alcohol consumption. According to SSB in 2020, 
consumption per capita in Norway was recorded to be as high as 7.23 litres (136). This also 
highlights dentists’ necessity in providing information to patients about the impact of alcohol 
on oral cancer. 
Oral cancer risk associated with older age also scored relatively higher (81.9%), which was 
higher than similar study conducted in Italy (137), Germany (121) and Yemen (138). 
Research in the related field reveals much higher prevalence of oral cancer cases is seen in 
elderly population compared to younger people (139). One of the reasons why elderly people 
are more likely to develop oral cancer is reduction in the salivary antioxidants in the salivary 
content and reduced capacity of combating oral carcinogens (139). At the same time, 
statistics Norway’s forecast strong ageing population with 940,000 Norwegians at the age 
over 65 and by the turn of the century, the number would be almost 2 million (140). The fact 
that most of the oral cancer cases are diagnosed in people aged 50 to 75, it is crucial that the 
oral health professionals are equipped with the knowledge and are aware of the risk for oral 




An interesting observation is that viral infections with HPV as a risk factor also scored 
relatively high (69.4%), although HPV is mainly considered as a risk factor for 
oropharyngeal cancers and not for oral cancers (141). While HPV is identified in around 90% 
of oropharyngeal cancer cases, little research has been conducted on prevalence of HPV in 
oral cancer. Nevertheless, available data shows that it is not higher than 6% (141). 
Regardless, it is positive that dental professionals are aware of high risks brought by HPV.  
Among all above mentioned risk factors, the score was lowest for low consumption of fruits 
and vegetables. This coincides with the scores from other similar studies conducted in Italy 
(25.8%), USA (25%) (137, 142). This trend might be difficult to interpret since different 
factors can influence knowledge about main risk factors. Consumption of fruits and 
vegetables is linked to decreased risk of several types of cancer, including oral cancer (143). 
In the light of this evidence, it is important that dentists are made aware of the positive 
impact of certain diets, especially among high-risk patients (143).  
 
Clinical characteristics for oral cancer  
The most common sites for oral cancer are considered as the tongue, rim of the tongue and 
floor of the mouth (144, 145). Rim of the tongue was identified correctly by 68.2% of the 
dentists followed by floor of the mouth at 60.7%. The number of respondents who correctly 
identified rim of the tongue and floor of the mouth in the present study was much higher than 
the study in Eurasian countries Moldova, Belarus and Armenia (132). An interesting point is 
that buccal/lip mucosa was incorrectly identified as commonest sites of oral cancer by 35% 
of the respondents, while approximately similar number of respondents (37.5%) also 
correctly identified tongue as the risk factor. Compared to similar studies conducted 
elsewhere, the percentage of dentists specifying the tongue as the most common sites for oral 
cancer was much lower than in Kuwait (85%), Yemen (45.7%), Maryland, USA (54%) and 
Belarus (51.8%), and higher than in Sudan (20.4 %) (108, 132, 138, 146, 147).  
Leukoplakia and erythroplakia are the two most common lesions of the oral cavity that are 
likely to become malignant (148). These two lesions were also correctly identified by 
majority of the respondents in this study. Despite the fact oral erythroplakia is less common 
than the leukoplakia, its aggressive nature grabs attention of dental professionals (37) and 
could possibly be the reason that erythroplakia was identified by 83.2% of dentists compared 
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to leukoplakia at 80.4%. Looking at similar studies, 87% of dentists in Yemen, 88.5% of 
dentists in Belarus, 84.9% of dental students in Kuwait and 49.5% of dental students in 
Romania reported leukoplakia and erythroplakia as lesions most likely to be pre-cancerous 
(132, 138, 149, 150). Another interesting point is that blue nevus was incorrectly identified 
by 12.1% of the respondents. Blue nevus is a rare lesion of the oral cavity but higher 
prevalence on the skin (151). The risk of malignant transformation is also unknown 
particularly due to the rarity of the lesions (152), and common blue nevus remains unchanged 
throughout the life and the treatment is usually not required (153).  
The most common clinical properties of an early oral cancer lesion are small painless red or 
white areas/ulcerations with coarseness, and the elasticity of the soft tissues changes to harder 
sensation on palpation also known as induration (154). Small, painless, indurated ulceration 
was correctly identified by 73.6% of the dentists. This was followed by small, painless red 
and white areas by 46.4% and 31.4% respectively. In a similar study from Turkey, small 
painless red and white areas were identified by 26.5% and 35.9% respectively (117). 
Relatively high number (21.1%) of the dentists also incorrectly identified small, painful, 
indurated lesion as early cancer.  
The study findings discussed above show that there is a knowledge gap regarding common 
sites for oral cancer and clinical properties of an early cancer lesion among the respondents of 
the present study. At an early stage, oral cancerous lesions are usually asymptomatic and 
might be difficult to detect due to clinical similarities and size of the lesion (154). For this 
reason, it is crucial that the dental practitioners are conscious about what and where to look in 
order to detect oral cancer at an early stage. This knowledge gaps needs to be improved with 
systematic educational updates and educational interventions for dental professionals.  
 
Knowledge score on oral cancer prevention and early detection  
The distribution of the dentists according to the levels of knowledge about lesions with 
malignant potential, risk sites and clinical properties of early cancer lesions shows that more 
than half of the respondents (52.1%) had high knowledge score. When looking at the similar 
studies, it is observed that the knowledge score widely varies. For instance, study conducted 
in Iran, New York, Armenia (34%, 39% and 31.8% respectively) (120, 132, 142, 146), had 
lower knowledge score than the present study. However, we should note that higher 
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knowledge scores in the above-mentioned studies may be calculated differently, which makes 
it difficult to directly compare the results with data obtained in our study. The common factor 
however in these studies and the present study is that while a portion of the respondents show 
good knowledge on oral cancer there is also room for improvement suggesting steps should 
be made towards improving knowledge and education  
In the present study, there was no statistically significant association between higher level of 
knowledge and any of the investigated socio-demographic characteristics. When looking at 
the similar study from Iran, results reveals that the mean level of knowledge decreased with 
the dentists' age and working experience (120). At the same time, a study from Yemen 
showed that younger dentists recently graduated, indicated better knowledge (138). This 
might suggest that knowledge acquired tend to fade over time, implying the need for 
continuing education to not only keep updated on new knowledge, but to maintain older 
knowledge as well.  
Similarly, only 28.2% of the respondents listed textbooks as the source of information about 
oral mucosal screening and oral cancer prevention. This implies that the curriculum still 
might need changes to adequately cover the subject regarding mucosal examination and 
prevention of oral cancer in order to improve both knowledge and experience among the 
dental professionals in Norway.  
 
6.2.2 Practices related to oral cancer prevention and early detection 
With regards to oral mucosal examination for any lesions, 83.3% of the respondents reported 
that they perform examination of oral mucosa examination for all new patients. In contrast, 
slightly lower number of dentists (77.7%) reported to perform the examination also for all 
recall patients. The number of respondents performing screening of oral mucosa in the 
present study was higher in comparison to the studies conducted in Italy (53.8%) Australia 
(51.3%) and Sudan (46%), and rather similar to dental students’ practices in UK and results 
obtained from dentists in Kuwait, UK and Pakistan (108, 116, 128, 146, 149, 155-157), while 
the results were relatively lower for both the new and recall patients in comparison to the 
study conducted in Moldova and Belarus (132).  
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Comparatively low percentage of respondents reported that they perform oral mucosa 
examination on both new and recall patients for children under 20 years (68.9% and 65.4% 
respectively). Around 80% reported to perform the examination for patients aged 20-60 
years. In contrast, relatively high percentage of the respondents reported to perform the 
examination for older patients over 60 years on both new and recall patients (86.4% and 
81.8% respectively). As discussed earlier, older people are more prone to oral cancer 
compared to younger ones. It is therefore very positive finding that the respondents are aware 
about the risk associated with the advancing age and oral cancer. The results obtained in our 
study regarding oral cancer examinations are encouraging. However, the questionnaire used 
in the present study does not assemble any information on how accurate the examination was 
performed. Improper examination technique may lead to delayed diagnosis of the oral cancer 
lesions. 
In general, it was observed that a large part of the dentists (79.6%) had detected a suspicious 
lesion for oral cancer, while performing a biopsy was not as common. Compared to the 
dentists who has detected suspicious lesion for oral cancer, only around half (43.5%) of the 
respondents had performed biopsy of oral mucosa themselves. This may suggest, that when 
detecting a suspicious lesion, the dentists tend to refer the patient to a specialist to check for 
malignancy. The percentage of the dentists who had performed biopsy in the current study 
were much lower in comparison to the study conducted in Pakistan (59.5%) and Kuwait 
(62.9%) (146, 157) and much higher than the study in Eurasia (Moldova (17.5%), Belarus 
(12.5%) and Armenia (29.9%)) (132). Interestingly, only 9.9% of the dentists in United Arab 
Emirates reported that they feel comfortable performing a biopsy, and 84.9% reported the 
further need for training on oral cancer detection (158). Although the present study did not 
assess if our respondents feel competent in performing a biopsy and interpreting a biopsy 
report, we can presume that responses on these matters will be the same for the present study. 
This may indicate that giving the opportunity to the dental professional to perform a biopsy 
as a student (demonstration of biopsy technique) and show how a suspicious lesion for oral 
cancer looks like may have a positive impact on their knowledge and increase the ability of 
detecting oral cancer at an early stage.  
Furthermore, it was observed that the respondents are more likely to refer their patients 
detected with a suspicious lesion to a specialist. Around 80% of the dentists answered that 
they have referred to specialist. Majority of the respondents also answered that they had 
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referred the patients mostly to the oral surgeon. Regarding the respondents who has not 
referred to specialist, assumption can be that they might be hesitant to seek a second opinion 
from a specialist in order to correctly diagnose a patient. Furthermore, the older dentists with 
more of work experience, reported to have referred more patients to a specialist for 
suspicious lesion for oral cancer, compared to younger dentists and dentists with less work 
experience. A reasonable explanation might be that longer experience leads to more patients 
and more cases which needs to be referred.  
A high percentage of the respondents recognized providing counselling to patients regarding 
tobacco cessation as “quite often, always or almost always. There was no statistically 
significant difference was observed between dentists who smoke and those who don't smoke 
regarding counselling their patients on tobacco cessation. Despite alcohol is considered a 
major risk factor for oral cancer, very low percentage of the participants have reported to 
provide alcohol cessation counselling to their patients. Studies conducted previously shows 
that a large part of the dental personnel feel that they are inadequately trained and usually 
uncomfortable in providing recommendations on alcohol and tobacco cessation to their 
patients (155, 159). In contrast, many positive dentists’ responses on this matter were 
gathered in a study conducted in Italy - 80.9% and 76.5%, respectively (142). In order to 
increase awareness and chances of changing patients’ behaviour, dentists must be confident 
in their ability of discussing these statements with patients. This reinforces the need of 
implementing strategies in dental curricula and providing continuous education courses in the 
related matters.  
 
6.2.3 Opinions towards oral mucosal screening and oral cancer prevention  
The majority of the participants agreed that oral mucosal examination should occur for new 
and recall patients. In a similar study conducted in Australia, only 51.4% reported to perform 
mucosal examination for all patients. The respondents in the present study showed higher 
percentage regarding oral mucosal examination compared to the study in Australia. The 
finding also shows high number of respondents perform mucosal examination of 20-60 years 
and over 60 years old for both new and recall patients. This is a positive finding considering 
the average age at diagnosis for oral cancer is 62 and two-thirds of individuals with oral 




Regarding who should be responsible for oral mucosa screening on all new and recall 
patients, a high percentage of the respondents agreed or strongly agreed on the role of dentist. 
Interestingly, very high number of respondents strongly agreed that it is the role of dental 
hygienists to perform the examination on all new and recall patients (84.8% and 83% 
respectively. This may indicate our respondents’ belief that oral health professionals who can 
see patients regularly should also be aware of oral cancer in order to detect any changes in the 
oral mucosa at an early stage. A study in India regarding effectiveness in oral examination by 
trained health workers revealed that trained health workers were accurate in performing oral 
cancer examination (161).  
 
6.2.4 Perceived barriers to perform oral mucosal screening  
The respondents in the present study agreed that the lack of knowledge, training, and 
experience (28.4%, 34.9% and 36.0% respectively) were the common barriers to perform oral 
mucosal screening. However, results after the dichotomization of the response variables 
indicated no such barriers that keeps the respondents from performing mucosal screening. 
Looking at a similar study conducted in Moldova, Belarus and Armenia, relatively high 
percentage of dentists indicated lack of training and experience a potential barrier to perform 
oral mucosal examination (117, 132, 137). Similarly, data from studies in South Carolina and 
Yemen showed that dentists believe they need and/or interested in continuous education and 
training to improve their skills in oral cancer screening (138, 162). When looking at the 
studies where dentists were surveyed if they considered their knowledge up to date, reported 
the lowest number from Sudan at around 26% (108) and the highest from New York at 
around 72% (142). The numbers regarding these barriers may suggest that the participants 
understand the need for improvement in their knowledge and training. It was common for 
several studies that a larger number of participants still wanted improved education and 
knowledge even though they thought their knowledge was up to date. While this was not 
explicitly asked in our study, one can still assume that there is a possibility that it will be the 
same for Norway. 
However, positive outcome of one-year oral cancer educational intervention program for 
dentists in Northern Germany have been proven to be promising. The program resulted in 
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improvement of participants’ capability in oral mucosa examination and early cancer 
detection (163). The following positive outcome may indicate benefits of educational 
intervention for dentists in Norway and possibly reduce some of the barriers mentioned by 








Oral health professionals play an important role in prevention and early detection of oral 
cancer. They must be competent enough to perform a compressive oral examination and to 
give recommendations regarding the main risk factors for oral cancer. Results from the 
present study highlight the strengths as well as the gaps in dentists knowledge and practices 
related to oral cancer prevention and early detection in Norway. More than half of the 
dentists scored high on knowledge regarding risk factors, cancer sites and clinical properties 
regarding oral cancer. The most reported perceived barriers to oral mucosal examination were 
lack of knowledge, training, and experience. Data from the current study can be used as a 
foundation for future educational programs for dentists and can help to reinforce the dental 





8.0 Recommendations  
 
With regards to the findings from the present study, the following recommendations can be 
suggested:  
1. Improving dental curriculum to increase dentist’s knowledge on oral cancer 
prevention and early detection:  
• Dentists should practice in conducting a proper examination of the oral cavity 
at the student level. They should be trained in providing counselling regarding 
alcohol and tobacco cessation to the patients in order to prevent oral cancers 
and to improve public awareness on these matters.  
2. In order to maintain and improve dentists ́ knowledge on oral cancer, continuous 
regular educational interventions should be provided. This is a topic that needs current 
updating and repetition.  
 
3.  Implementing public health policies to promote a healthy diet and to stop/reduce 
smoking and alcohol consumption, will have a good impact on reducing oral cancer 
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Appendix 1. Questions/statements and corresponding scores of questions on knowledge 




Do you consider use of tobacco as a risk factor for oral cancer?
Yes 1
No 0
Do not know 0
Do you consider viral infection with HPV as a risk factor for oral cancer?
Yes 1
No 0
Do not know 0
Do you consider abusive use of alcohol as a risk factor for oral cancer?
Yes 1
No 0
Do not know 0
Do you consider older age as a risk factor for oral cancer?
Yes 1
No 0
Do not know 0
Do you consider low consumption of fruits and vegetables as a risk factor for oral cancer?
Yes 1
No 0
Do not know 0
Do you consider prior oral cancer lesion as a risk factor for oral cancer?
Yes 1
No 0






Do you consider the most common sites for oral cancer to be (Tick those that apply)
All sites equally 0




Retromolar region/palatopharyngeal arches 0
Tongue 1
Rim (sides) of tongue 1
Do not know 0






Do not know 0
Most common clinical properties of an early cancer lesion (Tick those that apply)
Small, painless white area 1
Small, painless red area 1
Small, painless, indurated ulceration 1
Small, painfull, indurated ulceration 0
Do not know 0
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1.  Female 
2.  Male 
3.  Others 
 




4. Where did you complete your basic degree as a dentist? 
1.  In Norway 
2.  Abroad 
 
5. Type of practice 
1.  Solo 
2.  Non-solo (several dentists in a practice) 
 
6. Specialty 
1.  General dentistry 
2.  Pediatric dentistry/orthodontics 
3.  Restorative/endodontics 
4.  Periodontics 
5.  Prosthodontics 
6.  Oral surgery 
7.  Oral pathology 
 
7. Do you check all new patients for oral mucosal (buccal, lip, floor of the mouth, tongue, 
base of tongue, palate, retromolar area and palatopharyngeal arches) lesions? 
1.  Yes  
2.  No 
3.  Do not remember 
 
8. If yes, which age-group new patients’ oral mucosa do you check? 
1.  Children under 20 
2.  20-60 
3.  Over 60 
 
9. Do you check all recall patients for oral mucosal lesions? 
1.  Yes  
2.  No 




10. If yes, which age-group recall patients’ oral mucosa do you check? 
4.  Children under 20 
5.  20-60 
6.  Over 60 
 
11. Have you ever detected a suspicious lesion for oral cancer? 
1.  Yes  
2.  No 
3.  Do not remember 
 
12. Have you ever referred further to a specialist for a suspicious lesion for oral cancer? 
1.  Yes 
2.  No 
3.  Do not remember 
 




14. Have you ever performed biopsy of oral mucosa? 
1.  Yes  
2.  No 
3.  Do not remember 
 
15. Dentists should perform examination of oral mucosa on all new patients. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
16. Dental hygienists should perform examination of oral mucosa on all new patients. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
17. Dentists should perform examination of oral mucosa on all recall patients. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
18. Dental hygienists should perform examination of oral mucosa on all recall patients. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 




19. Checking oral mucosa should be targeted to those at high risk of developing oral cancer. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
20. Lack of clinical time is a barrier to checking oral mucosa. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
21. Lack of financial incentives is a barrier to checking oral mucosa. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
22. Lack of knowledge in performing oral mucosa examination is a barrier to checking oral 
mucosa.  
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
23. Lack of training in performing oral mucosa examination is a barrier to checking oral 
mucosa. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
24.  Lack of experience in performing oral mucosa examination is a barrier to checking it. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
25. Do you consider use of tobacco as a risk factor for oral cancer? 
1.  Yes  
2.  No 




26. Do you consider viral infection with HPV as a risk factor for oral cancer? 
1.  Yes  
2.  No 
3.  Do not know 
 
27. Do you consider abusive use of alcohol as a risk factor for oral cancer? 
1.  Yes  
2.  No 
3.  Do not know 
 
28. Do you consider older age as a risk factor for oral cancer? 
1.  Yes  
2.  No 
3.  Do not know 
 
29. Do you consider low consumption of fruits and vegetables as a risk factor for oral cancer? 
1.  Yes  
2.  No 
3.  Do not know 
 
30. Do you consider prior oral cancer lesion as a risk factor for oral cancer? 
1.  Yes  
2.  No 
3.  Do not know 
 
31. How often do you smoke (cigarettes/pipe/cigar)? 
1.  Every day 
2.  Several times a week 
3.  Once a week 
4.  Several times a month 
5.  Seldom  
6.  Smoked but quitted 
7.  Never smoked  
 
32. How often do you smoke electronic cigarettes? 
8.  Every day 
9.  Several times a week 
10.  Once a week 
11.  Several times a month 
12.  Seldom  
13.  Smoked but quitted 
14.  Never smoked  
 
33. How often do you use snuff or chewing smokeless tobacco? 
1.  Every day 
2.  Several times a week 
3.  Once a week 
4.  Several times a month 
5.  Seldom 
6.  I used it before, but I quitted 




34. Do you give counselling to your patients regarding tobacco cessation? 
1.  Not at all  
2.  Seldom 
3.  Quite often 
4.  Always or almost always 
 
35. Do you give counselling to your patients regarding excessive alcohol cessation? 
1.  Not at all  
2.  Seldom 
3.  Quite often 
4.  Always or almost always 
 
36. Do you consider the most common sites for oral cancer to be (Tick those that apply) 
1.  all sites equally  
2.  floor of the mouth 
3.  buccal/lip mucosa 
4.  hard palate 
5.  soft palate 
6.  retromolar region/palatopharyngeal arches 
7.  tongue 
8.  rim (sides) of tongue 
9.  Do not know 
 
37. The two lesions most likely to be pre-cancerous are (You should tick 2 answers)  
1.  Morbus Chron  
2.  Erythroplakia  
3.  Blue nevus  
4.  Leukoplakia  
5.  Apthe 
6.  Do not know 
 
38. Most common clinical properties of an early cancer lesion (Tick those that apply)  
1.  small, painless white area  
2.  small, painless red area 
3.  small, painless, indurated ulceration 
4.  small, painful, indurated ulceration 
5.  Do not know 
 
39. Do you ask your patients about current/previous use of tobacco? 
1.  Yes  
2.  No 
3.  Do not remember 
 
40. Do you ask your patients about current/previous use of alcohol? 
1.  Yes  
2.  No 




41. Do you ask your patients about family history of cancer? 
1.  Yes  
2.  No 
3.  Do not remember 
 
42. You in current role as a dentist can influence a patient to reduce/quit smoking or drinking 
alcohol. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
43. You in current role as a dentist should provide smoking or alcohol cessation advice. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
44. It is the role of dental professionals to perform oral mucosal screening. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
45. It is the role of medical doctors/family doctor/specialists to perform oral mucosal 
screening. 
1.  Strongly disagree 
2.  Disagree 
3.  Do not know 
4.  Agree 
5.  Strongly agree 
 
46. Where did you get the information about oral mucosal screening and oral cancer 
prevention? (Tick those that apply) 
1.  Undergraduate courses 
2.  Postgraduate courses 
3.  Textbooks 
4.  Scientific journals 
5.  Dental congresses 
 








Appendix 3. Information letter and consent form  
 
Are you interested in taking part in the research project  
”Oral cancer prevention and oral mucosal examination among dentists in Norway – a cross-
sectional study”?  
This is an inquiry to participate in a research project where the main purpose is to gather 
information about knowledge, opinions and practices related to oral mucosal examination and 
prevention of oral diseases among dentists in Norway. In this letter, we will give you 
information about the purpose of the project and what your participation will involve.  
Purpose of the project  
The purpose of this project to provide information about knowledge, opinions and practices 
related to oral mucosal examination and prevention of oral cancer among dentists in Norway. 
The project is part of wider project that aims to create common standardized oral pathology 
teaching curriculum, and to initiate common research activity in this field. The finding of this 
study will help to identify the level of knowledge, opinions and practices regarding 
prevention of oral diseases among dentists.  
Who is responsible for the research project?  
University of Bergen is the institution responsible for the project. The present study is part of 
the oral pathology collaboration project, financed by Norwegian Centre for International 
Cooperation in Education (CPEA-LT-2016/10106).  
Why are you being asked to participate?  
You are being asked to participate in this study because you are actively practicing dentistry 
in the public dental health service. All actively practicing dentists in the public dental health 
services are invited to participate in the study.  
What does participation involve for you?  
Participation involves filling out a questionnaire. It will take about 15-20 minutes to complete 
the questionnaire. The questionnaire consists of 47–items regarding following sections: 1. 
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Personal data, 2. Competency and orientation in preventive care, 3. Preventive knowledge, 4. 
Preventive practice for patients and 5. Oral mucosal screening and oral cancer prevention.  
Participation is voluntary  
Participation is voluntary. If you chose to participate, you can withdraw your consent at any 
time without giving a reason. All information about you will then be made anonymous. There 
will be no negative consequences for you if you chose not to participate or later decide to 
withdraw.  
 
Your personal privacy – how we will store and use your personal data  
We will only use your personal data only for the purpose specified in this information letter. 
We will process your personal data confidentially and in accordance with data protection 
legislation (the General Data Protection Regulation and Personal Data Act). To ensure 
confidentially and anonymity your name or identification will not be included in the 
questionnaires. University of Bergen (Norway) is responsible for the project, and only the 
project leader and the master student collecting data (University of Bergen) will have access 
to the personal data. This letter of informed consent will only be kept for as long as the study 
is in progress. All information data will only be analysed for research purposes; all 
information will be anonymous and analysed without any reference to your name. The results 
will be used in the students' project and can be published in international journals.  
What will happen to your personal data at the end of the research project?  
The project is scheduled to end in June 2021. Indirectly identifiable information will be 
stored by UiB to 2021 and be available for analysis and research purposes.  
Your rights  
So long as you can be identified in the collected data, you have the right to:  
• access the personal data that is being processed about you  
• request that your personal data is deleted  
• request that incorrect personal data about you is corrected/rectified  
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• receive a copy of your personal data (data portability), and  
• send a complaint to the Data Protection Officer or The Norwegian Data Protection 
Authority regarding the processing of your personal data  
What gives us the right to process your personal data?  
We will process your personal data based on your consent. Based on an agreement with 
University of Bergen, NSD – The Norwegian Centre for Research Data AS has assessed that 
the processing of personal data in this project is in accordance with data protection 
legislation.  
Where can I find out more?  
If you have questions about the project, or want to exercise your rights, contact:  
• Professor Daniela Costea, University of Bergen, Daniela.costea@uib.no, Tel 
+4748352677  
• Professor Anne Christine Johannessen, University of Bergen, 
anne.johannessen@uib.no, +4755973230 
• Dinbandhu Thakur Lohar University of Bergen, dinbandhu67@yahoo.com, Tel 
+4747801004 
• NSD – The Norwegian Centre for Research Data AS, email: 
personverntjenester@nsd.no or telephone: +47 55 58 21 17.  
 
Yours sincerely, 
Professor Daniela Costea, Project Leader   Dinbandhu Thakur, MPhil Candidate  
 
I have received and understood information about the project “Oral cancer prevention and 
oral mucosal examination among dentists in Norway – a cross-sectional study” and have been 
given the opportunity to ask questions. I give consent:  
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to participate in this survey based on self-administered questionnaire 
 
 
(Signed by participant - clicked a box in the electronic format that allows further access to the 
questions)  
 
